★ Sign in to follow
HK

Henrik Krook

Executive
SE·Finansinspektionen
Egetis Therapeutics AB (publ)
Insider activity · 24 months6 buys1 saleCumulative net flow
Total declarations
18
Company
1
▲ Purchases (15 ops.)
€152k
▼ Sales (2 ops.)
€183k

Latest filing published 03 Sept 2026 for Egetis Therapeutics AB (publ).

Filing timeline

BuySale
Henrik Krook

Insider track record

Disclosed buys
15
Disclosed sells
2
Signal history

Closed purchases

Market purchases
15

Not enough history yet: 0 closed purchases, at least 2 are needed.

Purchases by company

Henrik Krook: trading record in brief

Henrik Krook is a declared insider of Egetis Therapeutics AB (publ) (chief executive), with filings sourced from Finansinspektionen. The record holds 18 filings, for trades running from 28 April 2021 to 31 August 2026.

The open-market side counts 15 purchases for €152k alongside 2 sales for €183k. The totals exclude 4 filings filed without an amount. Open-market purchases are the filings investors watch most closely, because the insider pays for the shares out of pocket. 2026 to date brings 3 purchases and 1 sale.

A typical purchase (the median) is worth €15k. On 8 out of 10 purchases, another insider of the same company was buying within the same 30 days. A cluster is several different insiders buying the same stock within a short window, a pattern studied more closely than a single purchase.

The newest entry dates from 3 September 2026: an open-market purchase, in Egetis Therapeutics AB (publ). Filings reach the Finansinspektionen feed a median of 3 days after the trade. The regulation allows three business days to notify a trade (MAR article 19). This summary is built from Finansinspektionen disclosures alone and does not predict where the share price will go.

Companies and markets linked to Henrik Krook

Open company profiles for insider transactions, fundamentals and analyst consensus when available.

Declarations18 total
  • ▲
    Henrik Krook
    Annan medlem i bolagets administrations-, lednings- eller kontrollorganExecutivesEgetis Therapeutics AB (publ)
    0FI-SE
    1,099 shares0AktieISIN SE0003815604FI:csv-24e02d5ee31cbbc703d2
    Canonical exit: 29 Nov 2026 (T+90)
  • ▼
    Henrik Krook
    Annan medlem i bolagets administrations-, lednings- eller kontrollorganExecutivesEgetis Therapeutics AB (publ)
    2M SEK30FI-SE
    264,880 shares@ SEK 6.500.054% mcap94.6% of flowAktieISIN SE0003815604FI:csv-4f6c60d76c6f9c961f8e
  • ▲
    Henrik Krook
    Annan medlem i bolagets administrations-, lednings- eller kontrollorganExecutivesEgetis Therapeutics AB (publ)
    0FI-SE
    264,880 shares0AktieISIN SE0003815604FI:csv-5062421e5700a2577d48
    Canonical exit: 9 Aug 2026 (T+90)
  • ▲
    Henrik Krook
    Annan medlem i bolagets administrations-, lednings- eller kontrollorganExecutivesEgetis Therapeutics AB (publ)
    0FI-SE
    264,880 shares0AktieISIN SE0003815604FI:A003Y615-1
    Canonical exit: 9 Aug 2026 (T+90)
  • ▲
    Henrik Krook
    Annan medlem i bolagets administrations-, lednings- eller kontrollorganExecutivesEgetis Therapeutics AB (publ)
    98,500 SEK20FI-SE
    25,000 shares@ SEK 3.940.0031% mcap5.4% of flowAktieISIN SE0003815604FI:A003U240-1
    Canonical exit: 24 Feb 2026 (T+90)
  • ▲
    Henrik Krook
    Annan medlem i bolagets administrations-, lednings- eller kontrollorganExecutivesEgetis Therapeutics AB (publ)
    51,300 SEK19FI-SE
    15,000 shares@ SEK 3.421.5% of flowAktieISIN SE0003815604FI:csv-1c7b8ed617d97cba8975
    Canonical exit: 31 Aug 2025 (T+90)
  • ▲
    Henrik Krook
    Annan medlem i bolagets administrations-, lednings- eller kontrollorganExecutivesEgetis Therapeutics AB (publ)
    51,450 SEK19FI-SE
    15,000 shares@ SEK 3.431.5% of flowAktieISIN SE0003815604FI:csv-24379eb10ceaaaf35dde
    Canonical exit: 31 Aug 2025 (T+90)
  • ▲
    Henrik Krook
    Annan medlem i bolagets administrations-, lednings- eller kontrollorganExecutivesEgetis Therapeutics AB (publ)
    280,150 SEK20FI-SE
    65,000 shares@ SEK 4.316.5% of flowAktieISIN SE0003815604FI:csv-502317424850b3d15801
    Canonical exit: 6 Feb 2025 (T+90)
  • ▲
    Henrik Krook
    Annan medlem i bolagets administrations-, lednings- eller kontrollorganExecutivesEgetis Therapeutics AB (publ)
    133,704 SEK25FI-SE
    33,594 shares@ SEK 3.983.0% of flowAktieISIN SE0003815604FI:csv-f22e21492621a820d1de
    Canonical exit: 5 Oct 2023 (T+90)
  • ▲
    Henrik Krook
    Annan ledande befattningshavareExecutivesEgetis Therapeutics AB (publ)
    281,177 SEK0FI-SE
    84,999 shares@ SEK 3.3087.8% of flowAktieISIN SE0003815604FI:csv-a228c8a618ac726d7719
    Canonical exit: 18 Sept 2022 (T+90)
  • ▼
    Henrik Krook
    Annan ledande befattningshavareExecutivesEgetis Therapeutics AB (publ)
    274,292 SEK3FI-SE
    84,999 shares@ SEK 3.2277.6% of flowAktieISIN SE0003815604FI:csv-e5983c6af5263fce7d3d
  • ●
    Henrik Krook
    Annan ledande befattningshavareExecutivesEgetis Therapeutics AB (publ)
    496,396 SEK0FI-SE
    135,999 shares@ SEK 3.6514.0% of flowBTA (betald tecknad aktie)ISIN SE0017770027FI:csv-2ddb418a7b8819e50271
  • ▲
    Henrik Krook
    Annan ledande befattningshavareExecutivesEgetis Therapeutics AB (publ)
    0FI-SE
    283,330 shares0Teckningsrätt/UniträttISIN SE0003815604FI:csv-674be4ca186f056691cf
    Canonical exit: 11 Aug 2022 (T+90)
  • ▲
    Henrik Krook
    Annan ledande befattningshavareExecutivesEgetis Therapeutics AB (publ)
    183,000 SEK14FI-SE
    30,000 shares@ SEK 6.104.8% of flowAktieISIN SE0003815604FI:csv-f450e28c0a8615fd037a
    Canonical exit: 28 Dec 2021 (T+90)
  • ▲
    Henrik Krook
    Annan ledande befattningshavareExecutivesEgetis Therapeutics AB (publ)
    167,333 SEK2FI-SE
    31,045 shares@ SEK 5.394.4% of flowAktieISIN SE0003815604FI:csv-9e9d5c3817ecbed16924
    Canonical exit: 17 Nov 2021 (T+90)
  • ▲
    Henrik Krook
    Annan ledande befattningshavareExecutivesEgetis Therapeutics AB (publ)
    151,578 SEK14FI-SE
    27,000 shares@ SEK 5.6144.0% of flowAktieISIN SE0003815604FI:csv-f8550c3c0b0e57086896
    Canonical exit: 28 Sept 2021 (T+90)
  • ▲
    Henrik Krook
    Annan ledande befattningshavareExecutivesEgetis Therapeutics AB (publ)
    44,800 SEK14FI-SE
    8,000 shares@ SEK 5.601.2% of flowAktieISIN SE0003815604FI:csv-5cbfe77bc1ba639eea92
    Canonical exit: 29 Sept 2021 (T+90)
  • ▲
    Henrik Krook
    Annan ledande befattningshavareExecutivesEgetis Therapeutics AB (publ)
    187,800 SEK2FI-SE
    30,000 shares@ SEK 6.265.0% of flowAktieISIN SE0003815604FI:csv-b9821f1d85df584f720d
    Canonical exit: 27 Jul 2021 (T+90)

18 of 18 declarations

Related entities

No related entities found.